Trial
NCT06725264
Tyrosine Kinase 2 (TYK2) for GA and CS
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Bristol-Myers Squibb
Condition
Sarcoidosis
Intervention
Deucravacitinib
Why stopped
Funding was rescinded.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-29